These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32043370)

  • 1. Prostaglandin analogues: A double-edged sword in orbital glaucoma disease management.
    Joganathan V; Cannon PS; Mercieca K
    Eur J Ophthalmol; 2021 May; 31(3):NP40-NP44. PubMed ID: 32043370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues.
    El Ameen A; Vandermeer G; Khanna RK; Pisella PJ
    Eur J Ophthalmol; 2019 Nov; 29(6):645-653. PubMed ID: 30301370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma.
    Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF
    Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
    Stjernschantz J; Selén G; Astin M; Resul B
    Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma.
    Seong HJ; Lee K; Lee SJ; Kim S; Park JW
    Korean J Ophthalmol; 2021 Jun; 35(3):235-241. PubMed ID: 34120423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of Prostaglandin-Associated Periorbitopathy after Discontinuing Treatment.
    Abalo-Lojo JM; Ferreiro PV; Asorey MK; Colmenero AE; Gonzalez F
    Turk J Ophthalmol; 2023 Feb; 53(1):8-12. PubMed ID: 36847619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma.
    Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M
    J Ocul Pharmacol Ther; 2023; 39(1):63-69. PubMed ID: 36318495
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension.
    Hommer A
    Drugs Today (Barc); 2010 Jun; 46(6):409-16. PubMed ID: 20571609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculoplastic considerations in patients with glaucoma.
    Tan P; Malhotra R
    Surv Ophthalmol; 2016; 61(6):718-725. PubMed ID: 27045224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral orbital fat change.
    Yip IYM; Ramasamy B
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis.
    Harasymowycz P; Hutnik C; Rouland JF; Negrete FJM; Economou MA; Denis P; Baudouin C
    Adv Ther; 2021 Jun; 38(6):3019-3031. PubMed ID: 33891269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on Prostaglandin Orbitopathy.
    Custer PL; Kent TL
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):102-5. PubMed ID: 25719374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases.
    Schwartz GF; Kotak S; Mardekian J; Fain JM
    BMC Ophthalmol; 2011 Jun; 11():14. PubMed ID: 21672240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse periocular reactions to five types of prostaglandin analogs.
    Inoue K; Shiokawa M; Higa R; Sugahara M; Soga T; Wakakura M; Tomita G
    Eye (Lond); 2012 Nov; 26(11):1465-72. PubMed ID: 23037910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.